期刊
JOURNAL OF NUCLEAR MEDICINE
卷 53, 期 5, 页码 716-722出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.111.098988
关键词
Tc-99m-3PRGD2; integrin alpha(V)beta(3); lung cancer; multicenter study; SPECT
资金
- Capital Special Project for Featured Clinical Application [Z111107058811096]
- National Natural Science Foundation of China (NSFC) [30870725, 30870728, 30930030, 30900373, 81000625, 81071189, 81171369]
- Outstanding Youth Fund [81125011]
- 973 project [2011CB707703]
- Ministry of Science and Technology of China [2011YQ030114, 2012ZX09102301-018]
Tc-99m-3PRGD2 is a new SPECT tracer targeting integrin alpha(V)beta(3) receptor for detecting tumors, imaging angiogenesis, and evaluating tumor response to therapy. A multicenter study was designed to investigate the efficacy of Tc-99m-3PRGD2 for the evaluation of patients with lung cancer. Methods: Seventy patients (51 men, 19 women; mean age +/- SD, 63 +/- 9 y) with a suspected lung lesion and for whom definite pathologic diagnosis was finally obtained (malignant, n = 58; benign, n = 12) were recruited from 6 centers. Whole-body planar scanning and chest SPECT were performed at 1 and 4 h, respectively, after intravenous injection of 11.1 MBq/kg (0.3 mCi/kg) of (99)mTc-3PRGD2. The images were read in consensus by 6 experienced nuclear medicine physicians masked to the source, history, and pathologic diagnosis. The tumor-to-background (T/B) ratios were calculated for semiquantitative analysis. A Student t test was used for statistical analysis, and a P value less than 0.05 was considered significant. Results: With low Tc-99m-3PRGD2 background in the lungs and mediastinum, most lung malignancies were prominent on the 1-h images (T/B ratio, 1.65 +/- 0.47 for the planar imaging and 2.78 +/- 1.52 for SPECT). The T/B ratios were significantly lower in the benign lesions (P < 0.05). The sensitivity was 88% for semiquantitative analysis and could reach 93%-97% in visual analysis when considering the volume effect, necrosis, and metastasis. However, the specificity was only 58%-67%. Most lymph node and bone metastases could also be detected. Conclusion: Tc-99m-3PRGD2 imaging at 1 h is sensitive for the detection of lung cancer, meriting further investigation of Tc-99m-3PRGD2 as a novel clinical tracer for integrin receptor imaging.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据